EEE

ECTIN RESEARCH AB SER. B

No trades
See on Supercharts
Market capitalization
‪6.41 M‬SEK
−1.358SEK
‪−17.23 M‬SEK
‪9.56 M‬
Beta (1Y)
0.66

About ECTIN RESEARCH AB SER. B

CEO
Anna Sjöblom-Hallén
Headquarters
Mölndal
Founded
2013
ISIN
SE0015987714
FIGI
BBG011N45SF9
Ectin Research AB operates as a pharmaceutical company. The firm develops a novel treatment that eliminates cancer tumors. Its drug candidate MFA-370, is under preclinical studies and aiming to treat metastatic bladder cancer, and other cancers such as breast, colorectal and prostate cancer cells. The company was founded by Christer Edlund, Marie-Lois Ivarsson, and Peter Falk on November 7, 2013 and is headquartered in Molndal, Sweden.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ECTIN.B is 0.446 SEK — it has decreased by 2.19% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NGM exchange ECTIN RESEARCH AB SER. B stocks are traded under the ticker ECTIN.B.
ECTIN.B stock is 11.22% volatile and has beta coefficient of 0.66. Check out the list of the most volatile stocks — is ECTIN RESEARCH AB SER. B there?
Yes, you can track ECTIN RESEARCH AB SER. B financials in yearly and quarterly reports right on TradingView.
ECTIN.B stock has fallen by 15.85% compared to the previous week, the month change is a 18.01% fall, over the last year ECTIN RESEARCH AB SER. B has showed a 34.80% decrease.
ECTIN.B net income for the last quarter is ‪−11.13 M‬ SEK, while the quarter before that showed ‪−2.15 M‬ SEK of net income which accounts for −416.72% change. Track more ECTIN RESEARCH AB SER. B financial stats to get the full picture.
Today ECTIN RESEARCH AB SER. B has the market capitalization of ‪6.41 M‬, it has decreased by 13.96% over the last week.
No, ECTIN.B doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ECTIN.B shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ECTIN RESEARCH AB SER. B stock right from TradingView charts — choose your broker and connect to your account.
ECTIN.B reached its all-time high on Sep 2, 2021 with the price of 6.600 SEK, and its all-time low was 0.300 SEK and was reached on Dec 28, 2023.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ECTIN RESEARCH AB SER. B technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ECTIN RESEARCH AB SER. B stock shows the strong sell signal. See more of ECTIN RESEARCH AB SER. B technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.